Who
Joseph E. Gilliam
Director
Company insider
Files Form 4 as: Director, Caris Life Sciences; President & COO, Glaukos.
In numbers
- Trades disclosed
- 309
- Buys
- 1
- Sells
- 45
- Bought
- $50K
- Sold
- $70.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 5 May 2017
- Last trade
- 14 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 14 Aug 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —13,192 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —13,192 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $485K10,000 at $48.46 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $1.1M20,000 at $55.18 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $1.1M20,000 at $55.18 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $485K10,000 at $48.46 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $5.0M27,963 at $178.89 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $5.8M32,037 at $180.49 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $485K10,000 at $48.46 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $1.1M20,000 at $55.18 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $1.1M20,000 at $55.18 | filing |
| 11 Aug 2026filed 13 Aug 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $485K10,000 at $48.46 | filing |
News
Glaukos Expands Retinal Pipeline With RevOpsis Deal - Orange County Business JournalGKOS · ocbj.com · 19 Oct 2026
0 headlines in the last 90 days name Joseph E. Gilliam; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.